{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T15:42:51Z","timestamp":1772898171330,"version":"3.50.1"},"reference-count":156,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[1999,1,1]],"date-time":"1999-01-01T00:00:00Z","timestamp":915148800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Med Klin"],"published-print":{"date-parts":[[1999,1]]},"DOI":"10.1007\/bf03044692","type":"journal-article","created":{"date-parts":[[2009,6,6]],"date-time":"2009-06-06T04:22:13Z","timestamp":1244262133000},"page":"29-38","source":"Crossref","is-referenced-by-count":18,"title":["Nichtenzymatische Glykierung und oxidativer Stre\u00df bei chronischen Erkrankungen und Diabetes mellitus","Non-enzymatic glycation and oxidative stress in chronic disease and diabetes mellitus"],"prefix":"10.1007","volume":"94","author":[{"given":"Peter P.","family":"Nawroth","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angelika","family":"Bierhaus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriele E.","family":"Vogel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marion A.","family":"Hofmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martina","family":"Zumbach","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Wahl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reinhard","family":"Ziegler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF03044692_CR1","first-page":"1662","volume":"10","author":"M Abel","year":"1995","unstructured":"Abel M, Ritthaler U, Zhang Y, et al. Expression of receptors for advanced glycosylated end products in renal disease. Nephrol Dial Transplant 1995;10:1662\u20137.","journal-title":"Nephrol Dial Transplant"},{"key":"BF03044692_CR2","first-page":"4889","volume":"261","author":"MU Ahmed","year":"1986","unstructured":"Ahmed MU, Thorpe SR, Baynes JW. Identification of carboxymethyllysine as a degradation product of fructose-lysine in glycosylated protein. J Biol Chem 1986;261:4889\u2013994.","journal-title":"J Biol Chem"},{"key":"BF03044692_CR3","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/0891-5849(93)90162-N","volume":"15","author":"K Asayama","year":"1993","unstructured":"Asayama K, Uchida M, Nakane T. Antioxidants in the serum of children with insulin dependent diabetes mellitus. Free Rad Biol Med 1993;15:597\u2013602.","journal-title":"Free Rad Biol Med"},{"key":"BF03044692_CR4","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0092-8674(00)81318-5","volume":"87","author":"PA Baeuerle","year":"1996","unstructured":"Baeuerle PA, Baltimore D. NF-kB: ten years after. Cell 1996;87:13\u201320.","journal-title":"Cell"},{"key":"BF03044692_CR5","first-page":"151","volume":"5","author":"H-J Baumgartl","year":"1996","unstructured":"Baumgartl H-J, Hofmann H, Standl E. Erh\u00f6hung der Serum-AGEs (\u201cadvanced glycosylation endproducts\u201d) bei Rauchem unter den Typ-1-Diabetikern. Diab Stoffw 1996;5:151 abstract.","journal-title":"Diab Stoffw"},{"key":"BF03044692_CR6","first-page":"177","volume":"5","author":"H-J Baumgartl","year":"1996","unstructured":"Baumgartl H-J, Standl E. \u201cAdvanced glycation end products\u201d und deren Folge f\u00fcr die diabetische Folgesch\u00e4den. Diab Stoffw 1996;5:177\u201382.","journal-title":"Diab Stoffw"},{"key":"BF03044692_CR7","doi-asserted-by":"crossref","first-page":"405","DOI":"10.2337\/diab.40.4.405","volume":"40","author":"JW Baynes","year":"1991","unstructured":"Baynes JW. Role of oxidative stress in development of complications in diabetes. Diabetes 1991;40:405\u201312.","journal-title":"Diabetes"},{"key":"BF03044692_CR8","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.2337\/diab.46.9.1481","volume":"46","author":"A Bierhaus","year":"1997","unstructured":"Bierhaus A, Chevion S, Chevion M, et al. Advanced glycation endproducts (AGEs) induced activation of NF-kB is suppressed by a-lipoic acid in cultured endothelial cells. Diabetes 1997;46:1481\u201390.","journal-title":"Diabetes"},{"key":"BF03044692_CR9","doi-asserted-by":"crossref","first-page":"2262","DOI":"10.1161\/01.CIR.96.7.2262","volume":"96","author":"A Bierhaus","year":"1997","unstructured":"Bierhaus A, Illmer T, Kasper M, et al. Advanced glycation endproducts (AGEs) mediated induction of tissue factor in cultured endothelial cells is dependent on RAGE. Circulation 1997;96:2262\u201371.","journal-title":"Circulation"},{"issue":"Suppl 5","key":"BF03044692_CR10","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1093\/ndt\/11.supp5.87","volume":"11","author":"A Bierhaus","year":"1996","unstructured":"Bierhaus A, Ritz E, Nawroth PP. Expression of receptors for advanced glycation end-products in occlusive vascular and renal disease. Nephrol Dial Transplant 1996;11:Suppl 5:87\u201390. abstract.","journal-title":"Nephrol Dial Transplant"},{"key":"BF03044692_CR11","first-page":"979","volume":"31","author":"HK Biesalski","year":"1995","unstructured":"Biesalski HK. Antioxidative Vitamine in der Pr\u00e4vention. Deutsch \u00c4rztebl 1995;31:979\u201383.","journal-title":"Deutsch \u00c4rztebl"},{"key":"BF03044692_CR12","first-page":"1699","volume":"143","author":"J Brett","year":"1993","unstructured":"Brett J, Schmidt AM, Yan SD, et al. Survey of the distribution of a newly characterized receptor for advanced glycation end products in tissues. Am J Pathol 1993;143:1699\u2013712.","journal-title":"Am J Pathol"},{"key":"BF03044692_CR13","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1146\/annurev.med.46.1.223","volume":"46","author":"M Brownlee","year":"1995","unstructured":"Brownlee M. Advanced protein glycosylation in diabetes and aging. Ann Rev Med 1995;46:223\u201334.","journal-title":"Ann Rev Med"},{"key":"BF03044692_CR14","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1097\/00060793-199608000-00003","volume":"3","author":"M Brownlee","year":"1996","unstructured":"Brownlee M. Advanced glycation end products in diabetic complications. Curr Opin Endocr Diab 1996;3:291\u20137.","journal-title":"Curr Opin Endocr Diab"},{"key":"BF03044692_CR15","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1056\/NEJM198805193182007","volume":"318","author":"M Brownlee","year":"1988","unstructured":"Brownlee M, Cerami A, Vlassara H. Advanced glycation end products in tissue and the biochemical basis of diabetic complications. N Engl J Med 1988;318:1315\u201321.","journal-title":"N Engl J Med"},{"key":"BF03044692_CR16","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1126\/science.3487117","volume":"232","author":"M Brownlee","year":"1986","unstructured":"Brownlee M, Vlassara H, Kooney A, et al. Aminoguanidine prevents diabetes-induced arterial wall protein crosslinking. Science 1986;232:1629\u201332.","journal-title":"Science"},{"key":"BF03044692_CR17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S1054-3589(08)60961-8","volume":"23","author":"R Bucala","year":"1992","unstructured":"Bucala R, Cerami A. Advanced glycosylation: chemistry, biology, and implications for diabetes and aging. Adv Pharmacol 1992;23:1\u201334.","journal-title":"Adv Pharmacol"},{"key":"BF03044692_CR18","doi-asserted-by":"crossref","first-page":"6434","DOI":"10.1073\/pnas.90.14.6434","volume":"90","author":"R Bucala","year":"1993","unstructured":"Bucala R, Makita Z, Koschinsky T, et al. Lipid advanced glycosylation: pathway for lipid oxidation in vivo. Proc Natl Acad Sci USA 1993;90:6434\u20138.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF03044692_CR19","doi-asserted-by":"crossref","first-page":"9441","DOI":"10.1073\/pnas.91.20.9441","volume":"91","author":"R Bucala","year":"1994","unstructured":"Bucala R, Makita Z, Vega G, et al. Modification of LDL by advanced glycosylation endproducts contributes to the dyslipidemia of diabetes and renal insufficiency. Proc Natl Acad Sci USA 1994;91:9441\u20135.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF03044692_CR20","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1073\/pnas.81.1.105","volume":"81","author":"R Bucala","year":"1984","unstructured":"Bucala R, Model P, Cerami A. Modification of DNA by reducing sugars: a possible mechanism for nucleic acid aging and age-related dysfunction in gene expression. Proc Natl Acad Sci USA 1984;81:105\u20139.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF03044692_CR21","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1172\/JCI118104","volume":"96","author":"NE Cameron","year":"1995","unstructured":"Cameron NE, Cotter MA. Neurovascular dysfunction in diabetic rats. Potential contribution of autoxidation and free radicals using transition metal chelating agents. J Clin Invest 1995;96:1159\u201363.","journal-title":"J Clin Invest"},{"key":"BF03044692_CR22","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1007\/BF00401423","volume":"35","author":"NE Cameron","year":"1991","unstructured":"Cameron NE, Cotter MA, Dines K, et al. Effects of aminoguanidine on peripheral nerve function and polyol pathway metabolites in streptozotocin-diabetes rats. Diabetologia 1991;35:946\u201350.","journal-title":"Diabetologia"},{"key":"BF03044692_CR23","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1046\/j.1365-2362.1997.710624.x","volume":"27","author":"O Chappey","year":"1997","unstructured":"Chappey O, Dosquet C, Wautier M-P, Wautier J-L. Advanced glycation end products, oxidant stress and vascular lesion. Eur J Clin Invest 1997;27:97\u2013108.","journal-title":"Eur J Clin Invest"},{"key":"BF03044692_CR24","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/S0140-6736(96)90013-6","volume":"347","author":"P Dandona","year":"1996","unstructured":"Dandona P, Thusu K, Cook S, et al. Oxidative damage to DNA in diabetes mellitus. Lancet 1996;347:444\u20135.","journal-title":"Lancet"},{"key":"BF03044692_CR25","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/0026-0495(94)90175-9","volume":"43","author":"G Mattia De","year":"1994","unstructured":"De Mattia G, Laurenti O, Bravi C, et al. Effect of aldose reductase inhibition on glutathione redox status in erythrocytes of diabetic patients. Metabolism 1994;43:965\u20138.","journal-title":"Metabolism"},{"key":"BF03044692_CR26","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/382211a0","volume":"382","author":"K Drickhammer","year":"1996","unstructured":"Drickhammer K. Breaking the curse of the AGEs. Nature 1996;382:211\u20132.","journal-title":"Nature"},{"key":"BF03044692_CR27","doi-asserted-by":"crossref","first-page":"10964","DOI":"10.1021\/bi00501a014","volume":"29","author":"JA Dunn","year":"1990","unstructured":"Dunn JA, Ahmed MU, Mutiashaw MH, et al. Reaction of ascorbate with lysine and protein under autoxidizing conditions: formation of N-epsilon-(carboxymethyl)lysine by reactions between lysine and products of autoxidation of ascorbate. Biochemistry 1990;29:10964\u201370.","journal-title":"Biochemistry"},{"key":"BF03044692_CR28","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1021\/bi00219a007","volume":"30","author":"JA Dunn","year":"1991","unstructured":"Dunn JA, McCance DR, Thorpe SR, et al. Age-dependent accumulation of N-epsilon-(carboxymethyl) lysine and N-epsilon-(carboxymethyl)-hydroxylysine in human skin collagen. Biochemistry 1991;30:1205\u201310.","journal-title":"Biochemistry"},{"key":"BF03044692_CR29","first-page":"11654","volume":"266","author":"D Dyer","year":"1991","unstructured":"Dyer D, Blackledge J, Thorpe S, et al. Formation of pentosidine during nonenzymatic browning of proteins by glucose: identification of glucose and other carbohydrates as possible precursors of pentosidine in vivo. J Biol Chem 1991;266:11654\u201360.","journal-title":"J Biol Chem"},{"key":"BF03044692_CR30","doi-asserted-by":"crossref","first-page":"2463","DOI":"10.1172\/JCI116481","volume":"91","author":"DG Dyer","year":"1993","unstructured":"Dyer DG, Dunn JA, Thorpe SR, et al. Accumulation of Maillard reaction products in skin collagen in diabetes and aging. J Clin Invest 1993;91:2463\u20139.","journal-title":"J Clin Invest"},{"key":"BF03044692_CR31","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1007\/BF00400859","volume":"35","author":"D Edelstein","year":"1992","unstructured":"Edelstein D, Brownlee M. Aminoguanidine ameliorates albuminuria in diabetic hypertensive rats. Diabetologia 1992;35:96\u20137.","journal-title":"Diabetologia"},{"key":"BF03044692_CR32","doi-asserted-by":"crossref","first-page":"26","DOI":"10.2337\/diab.41.1.26","volume":"41","author":"D Edelstein","year":"1992","unstructured":"Edelstein D, Brownlee M. Mechanistic studies of advanced glycosylation endproduct inhibition by aminoguanidine. Diabetes 1992;41:26\u20139.","journal-title":"Diabetes"},{"key":"BF03044692_CR33","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1016\/0026-0495(91)90122-D","volume":"40","author":"EN Ellis","year":"1991","unstructured":"Ellis EN, Good BH. Prevention of glomerular basement membrane thickening by aminoguanidine in experimental diabetes mellitus. Metabolism 1991;40:1016\u20139.","journal-title":"Metabolism"},{"key":"BF03044692_CR34","doi-asserted-by":"crossref","first-page":"9982","DOI":"10.1074\/jbc.271.17.9982","volume":"271","author":"MX Fu","year":"1996","unstructured":"Fu MX, Requena R, Jenkins A, et al. The advanced glycation end product, Ne-(Carboxymethyl)lysine, is a product of both lipid peroxidation and glycoxidation re-actions. J Biol Chem 1996;271:9982\u20136.","journal-title":"J Biol Chem"},{"key":"BF03044692_CR35","doi-asserted-by":"crossref","first-page":"676","DOI":"10.2337\/diab.43.5.676","volume":"43","author":"M-X Fu","year":"1994","unstructured":"Fu M-X, Wells-Knecht KJ, Blackledge JA, et al. Glycation, glycoxydation, and cross-linking of collagen by glucose. Kinetics, mechanisms and inhibition of late stages of the Maillard reaction. Diabetes 1994;43:676\u201383.","journal-title":"Diabetes"},{"key":"BF03044692_CR36","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/0891-5849(92)90036-G","volume":"13","author":"A Ghiselli","year":"1992","unstructured":"Ghiselli A, Laurenti O, De Mattia G, et al. Salicylate hydroxylation as an early marker of in vivo oxidative stress in diabetic patients. Free Rad Biol Med 1992;13:621\u20136.","journal-title":"Free Rad Biol Med"},{"key":"BF03044692_CR37","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1172\/JCI117296","volume":"94","author":"I Giardino","year":"1994","unstructured":"Giardino I, Edelstein D, Brownlee M. Nonenzymatic glycosylation in vitro and in bovine endothelial cells alters basic fibroblast growth factor activity: a model for intracellular glycosylation in diabetes. J Clin Invest 1994;94:110\u20137.","journal-title":"J Clin Invest"},{"key":"BF03044692_CR38","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1172\/JCI118563","volume":"97","author":"I Giardino","year":"1996","unstructured":"Giardino I, Edelstein D, Brownlee M. BCL-2 expression or antioxidants prevent hyperglycemia-induced formation of intracellular advanced glycation endproducts in bovine endothelial cells. J Clin Invest 1996;97:1422\u20138.","journal-title":"J Clin Invest"},{"key":"BF03044692_CR39","doi-asserted-by":"crossref","first-page":"257","DOI":"10.2337\/diacare.19.3.257","volume":"19","author":"D Giuglianu","year":"1996","unstructured":"Giuglianu D, Ceriello A. Oxidative stress and diabetic vascular complications. Diab Care 1996;19:257\u201367.","journal-title":"Diab Care"},{"key":"BF03044692_CR40","doi-asserted-by":"crossref","first-page":"10017","DOI":"10.1074\/jbc.270.17.10017","volume":"270","author":"MA Glomb","year":"1995","unstructured":"Glomb MA, Monnier V. Mechanism of protein modifications by glyoxal and glyceraldehyde, reactive intermediates of the Maillard reaction. J Biol Chem 1995;270:10017\u201326.","journal-title":"J Biol Chem"},{"key":"BF03044692_CR41","first-page":"11649","volume":"266","author":"SK Grandhee","year":"1991","unstructured":"Grandhee SK, Monnier VM. Mechanism of formation of the Maillard protein cross-link pentosidine. J Biol Chem 1991;266:11649\u201353.","journal-title":"J Biol Chem"},{"key":"BF03044692_CR42","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1093\/oxfordjournals.ndt.a027399","volume":"11","author":"J Greten","year":"1996","unstructured":"Greten J, Zhang Y, Wiesel R, et al. Expression of receptors for advanced glycation end products in uremia. Nephrol Dial Transpl 1996;11:786\u201390.","journal-title":"Nephrol Dial Transpl"},{"key":"BF03044692_CR43","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/S0002-9343(99)80347-7","volume":"98","author":"A Griesmacher","year":"1995","unstructured":"Griesmacher A, Kindhauser M, Andert SE, et al. Enhanced serum levels of thiobarbituric acid reactive substances in diabetes mellitus. Am J Med 1995;98:469\u201375.","journal-title":"Am J Med"},{"key":"BF03044692_CR44","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1083\/jcb.134.1.13","volume":"134","author":"S Grimm","year":"1996","unstructured":"Grimm S, Bauer MKA, Bacuerle PA, et al. Bcl-2 down-regulates the activity of the transcription factor NF-kB upon apoptosis. J Cell Biol 1996;134:13\u201323.","journal-title":"J Cell Biol"},{"key":"BF03044692_CR45","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1006\/bbrc.1995.1935","volume":"212","author":"A Gugliucci","year":"1995","unstructured":"Gugliucci A, Bendayan M. Histones from diabetic rats contain increased levels of advanced glycation end products. Biochem Biophys Res Commun 1995;212:56\u201362.","journal-title":"Biochem Biophys Res Commun"},{"issue":"Suppl 5","key":"BF03044692_CR46","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1093\/ndt\/11.supp5.95","volume":"11","author":"Y Hamada","year":"1996","unstructured":"Hamada Y, Araki N, Horiuchi S, et al. Role of polyol pathway in nonenzymatic glycation. Nephrol Dial Transplant 1996;11:Suppl 5:95\u20138.","journal-title":"Nephrol Dial Transplant"},{"key":"BF03044692_CR47","first-page":"42","volume":"1","author":"HP Hammes","year":"1996","unstructured":"Hammes HP. Neue Therapie der diabetischen Mikroangiopathie. Diabetes J 1996;1:42\u20135.","journal-title":"Diabetes J"},{"key":"BF03044692_CR48","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1007\/BF00428774","volume":"37","author":"H-P Hammes","year":"1994","unstructured":"Hammes H-P, Brownlee M, Edelstein D, et al. Aminoguanidine inhibits the development of accelerated diabetic retinopathy in the spontaneous hypertensive rat. Diabetologia 1994;37:32\u20135.","journal-title":"Diabetologia"},{"key":"BF03044692_CR49","doi-asserted-by":"crossref","first-page":"11555","DOI":"10.1073\/pnas.88.24.11555","volume":"88","author":"HP Hammes","year":"1991","unstructured":"Hammes HP, Martin S, Federlin K, et al. Aminoguanidine treatment inhibits the development of experimental diabetic retinopathy. Proc Natl Acad Sci USA 1991;88:11555\u20138.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF03044692_CR50","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1042\/bst022399s","volume":"2","author":"AR Hipkiss","year":"1994","unstructured":"Hipkiss AR, Michaelis J, Syrris P, et al. Carnosine protects against in vitro glycation and cross-linking. Biochem Soc Trans 1994;2:399.","journal-title":"Biochem Soc Trans"},{"key":"BF03044692_CR51","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1080\/07328309208018277","volume":"11","author":"J Hirsch","year":"1992","unstructured":"Hirsch J, Baines CL, Feather MS. X-ray structures of a 3-amino-5-and a 3-amino-6-substituted triazine, producedas a result of reaction of 3-deoxy-D-erythrhexo-2-ulose (3-deoxyglucosone) with aminoguanidine. J Carbohydr Chem 1992;11:891\u2013901.","journal-title":"J Carbohydr Chem"},{"issue":"Suppl 1","key":"BF03044692_CR52","first-page":"105","volume":"6","author":"M Hofmann","year":"1997","unstructured":"Hofmann M, Bierhaus A, Zumbach M, et al. Schlechte diabetische Stoffwechselkontrolle f\u00fchrt zur Aktivierung des Transskriptionsfaktors NF-kB. Diab Stoffw 1997;6:Suppl 1:105. abstract.","journal-title":"Diab Stoffw"},{"key":"BF03044692_CR53","doi-asserted-by":"crossref","first-page":"25752","DOI":"10.1074\/jbc.270.43.25752","volume":"270","author":"O Hori","year":"1995","unstructured":"Hori O, Brett J, Slattery T, et al. The receptor for advanced glycation end products (RAGE) is a cellular binding site for amphoterin. J Biol Chem 1995;270:25752\u201361.","journal-title":"J Biol Chem"},{"key":"BF03044692_CR54","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1172\/JCI116716","volume":"92","author":"MSP Hujiberts","year":"1993","unstructured":"Hujiberts MSP, Wolffenbuttel BRH, Boudier HA, et al. Aminoguanidine treatment increases elasticity and decreases fluid filtration of large arteries from diabetic rats. J Clin Invest 1993;92:1407\u201311.","journal-title":"J Clin Invest"},{"key":"BF03044692_CR55","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1042\/bj2560205","volume":"256","author":"JV Hunt","year":"1988","unstructured":"Hunt JV, Dean RT, Wolff SP. Hydroxyl radical production and autoxidative glycosylation: glucose autoxidation as the cause of protein damage in the experimental glycation model of diabetes and aging. Biochem J 1988:256:205\u201312.","journal-title":"Biochem J"},{"key":"BF03044692_CR56","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.2337\/diab.39.11.1420","volume":"39","author":"JV Hunt","year":"1990","unstructured":"Hunt JV, Smith CCT, Wolff SP. Autoxidative glycosylation and possible involvement of peroxides and free radicals in LDL modifications. Diabetes 1990;39:1420\u20134.","journal-title":"Diabetes"},{"key":"BF03044692_CR57","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/0014-5793(90)80974-N","volume":"268","author":"ZY Jiang","year":"1990","unstructured":"Jiang ZY, Woolard ACS, Wolff SP. Hydrogen peroxide production during experimental protein glycation. FEBS Lett 1990;268:69\u201371.","journal-title":"FEBS Lett"},{"key":"BF03044692_CR58","doi-asserted-by":"crossref","first-page":"526","DOI":"10.2337\/diab.34.6.526","volume":"34","author":"CW Karpen","year":"1985","unstructured":"Karpen CW, Cataland S, Dorisson TM, et al. Production of 12-hydroyeicosatetraenoic acid and vitamin E status in platelets from type I human diabetic subjects. Diabetes 1985;34:526\u201331.","journal-title":"Diabetes"},{"key":"BF03044692_CR59","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1016\/0024-3205(88)90484-5","volume":"43","author":"M Khatami","year":"1988","unstructured":"Khatami M, Suldan Z, David I, Li W, et al. Inhibitory effects of pyridoxal phosphate, ascorbate and aminoguanidine on nonenzymatic browning. Life Sci 1988; 43:1725\u201331.","journal-title":"Life Sci"},{"key":"BF03044692_CR60","doi-asserted-by":"crossref","first-page":"6107","DOI":"10.1073\/pnas.88.14.6107","volume":"88","author":"M Kihara","year":"1991","unstructured":"Kihara M, Schmelzer JD, Poduslo JF, et al. Aminoguanidine effects on nerve blood flow, vascular permeability, electrophysiology and oxygene free radicals. Proc. Natl Acad Sci USA 1991;88:6107\u201311.","journal-title":"Proc. Natl Acad Sci USA"},{"key":"BF03044692_CR61","doi-asserted-by":"crossref","first-page":"190","DOI":"10.2337\/diab.40.2.190","volume":"40","author":"KJ Knecht","year":"1991","unstructured":"Knecht KJ, Dunn JA, McFarland KF, et al. Effect of diabetes and aging on carboxymethyllysine levels in human urine. Diabetes 1991;40:190\u20136.","journal-title":"Diabetes"},{"key":"BF03044692_CR62","doi-asserted-by":"crossref","first-page":"6474","DOI":"10.1073\/pnas.94.12.6474","volume":"94","author":"T Koschinsky","year":"1997","unstructured":"Koschinsky T, He CJ, Mitsuhashi T, et al. Orally absorbed reactive glycation products (glycotoxins): an environmental risk factor in diabetic nephropathy. Proc Natl Acad Sci USA 1997;94:6474\u20139.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF03044692_CR63","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/0167-4889(95)00028-Q","volume":"1266","author":"S Krantz","year":"1995","unstructured":"Krantz S, Salazar R, Brandt R, et al. Purification and partial amino acid sequencing of a fructosyllysine-specific binding protein from cell membranes of the monocyte-like cell line U937. Biochim Biophys Acta 1995;1266:109\u201312.","journal-title":"Biochim Biophys Acta"},{"key":"BF03044692_CR64","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1056\/NEJM199605023341803","volume":"18","author":"L Kushi","year":"1996","unstructured":"Kushi L, Folsom AR, Prineas RJ, et al. Dietary antioxidant vitamins and death from coronary heart disease in postmenopausal women. N Engl J Med 1996;18:1156\u201362.","journal-title":"N Engl J Med"},{"key":"BF03044692_CR65","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1002\/ange.19901020604","volume":"102","author":"F Ledl","year":"1990","unstructured":"Ledl F, Schleicher E. Die Maillard-Reaktion in Lebensmitteln und im menschlichen K\u00f6rper \u2014 neue Ergebnisse zu Chemie, Biochemie und Medizin. Angewandte Chemie 1990;102:597\u2013634.","journal-title":"Angewandte Chemie"},{"issue":"Suppl 2","key":"BF03044692_CR66","first-page":"24","volume":"6","author":"W Leonhardt","year":"1997","unstructured":"Leonhardt W, Hanefeld M, Lattke P, et al. Vitamin E-Mangel und Oxidierbarkeit der Low-Density-Lipoproteine bei Typ-I- und Typ-II-Diabetes: Einflu\u00df der Qualit\u00e4t der Stoffwechselkontrolle. Diab Stoffw 1997;6: Suppl 2: 24\u20138.","journal-title":"Diab Stoffw"},{"key":"BF03044692_CR67","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/0014-4835(90)90033-Q","volume":"50","author":"BS Lewis","year":"1990","unstructured":"Lewis BS, Harding JJ. The effects of aminoguanidine on the glycation (nonenzymatic glycosylation) of lens proteins. Exp Eye Res 1990;50:463\u20137.","journal-title":"Exp Eye Res"},{"key":"BF03044692_CR68","doi-asserted-by":"crossref","first-page":"3902","DOI":"10.1073\/pnas.93.9.3902","volume":"93","author":"Y-M Li","year":"1996","unstructured":"Li Y-M, Steffes M, Donnelly T, et al. Prevention of cardiovascular and renal pathology of aging by the advanced glycation inhibitor aminoguanidine. Proc Natl Acad Sci USA 1996;93:3902\u20137.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF03044692_CR69","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1038\/nm1095-1057","volume":"1","author":"Y-M Li","year":"1995","unstructured":"Li Y-M, Tan A-X, Vlassara H. Antibacterial activity of lysozyme and lactoferrin is inhibited by binding of advanced glycation-modified proteins to a conserved motif. Nat Med 1995;1:1057\u201361.","journal-title":"Nat Med"},{"key":"BF03044692_CR70","doi-asserted-by":"crossref","first-page":"11047","DOI":"10.1073\/pnas.93.20.11047","volume":"93","author":"YM Li","year":"1996","unstructured":"Li YM, Wojciehowicz D, Gilmore P, et al. Molecular identity and tissue distribution of advanced glycation endproduct receptors: relationship of p60 to OST-48 and 80KH membrane proteins. Proc Natl Acad Sci USA 1996;93:11047\u201352.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF03044692_CR71","first-page":"66","volume":"154","author":"LC Maillard","year":"1912","unstructured":"Maillard LC. Action des acides amines sur les sucres; formation des melanoides par voie methodique. C R Acad Sci 1912:154:66.","journal-title":"C R Acad Sci"},{"key":"BF03044692_CR72","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1016\/S0140-6736(94)92935-1","volume":"343","author":"Z Makita","year":"1994","unstructured":"Makita Z, Bucala R, Rayfield EJ, et al. Reactive glycosylation endproducts in diabetic uraemia and treatment of renal failure. Lancet 1994;343:1519\u201322.","journal-title":"Lancet"},{"key":"BF03044692_CR73","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1056\/NEJM199109193251202","volume":"325","author":"Z Makita","year":"1991","unstructured":"Makita Z, Radoff S, Rayfield EJ, et al. Advanced glycosylation endproducts in patients with diabetic nephropathy. N Engl J Med 1991; 325:836\u201342.","journal-title":"N Engl J Med"},{"key":"BF03044692_CR74","first-page":"5133","volume":"267","author":"Z Makita","year":"1992","unstructured":"Makita Z, Vlassara H, Cerami A, et al. Immunochemical detection of advanced glycosylation endproducts in vivo. J Biol Chem 1992;267:5133\u20138.","journal-title":"J Biol Chem"},{"key":"BF03044692_CR75","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1126\/science.1411574","volume":"258","author":"Z Makita","year":"1992","unstructured":"Makita Z, Vlassara H, Rayfield E, et al. Hemoglobin-AGE: a circulating marker of advanced glycosylation. Science 1992;258:651\u20133.","journal-title":"Science"},{"key":"BF03044692_CR76","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/1056-8727(95)80018-A","volume":"9","author":"Z Makita","year":"1995","unstructured":"Makita Z, Yanagisawa K, Kuwajima S, et al. Advanced glycation endproducts and diabetic nephropathy. J Diab Compl 1995;9:265\u20138.","journal-title":"J Diab Compl"},{"key":"BF03044692_CR77","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1038\/382674a0","volume":"382","author":"MP Mattson","year":"1996","unstructured":"Mattson MP, Rydel RE. Amyloid ox-tox transducers. Nature 1996;382:674\u20135.","journal-title":"Nature"},{"key":"BF03044692_CR78","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1042\/cs0870021","volume":"87","author":"AC McLellan","year":"1994","unstructured":"McLellan AC, Thornalley PJ, Benn J, et al. Glyoxalase system in clinical diabetes mellitus and correlation with diabetic complications. Clin Sci Colch 1994;87: 21\u20139.","journal-title":"Clin Sci Colch"},{"key":"BF03044692_CR79","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1172\/JCI118889","volume":"98","author":"T Miyata","year":"1996","unstructured":"Miyata T, Hori O, Zhang J, et al. The receptor for advanced glycation end products (RAGE) is a central mediator of the interaction of AGE-beta-2 microglobulin with human mononuclear phagocytes via an oxidant sensitive pathway. J Clin Invest 1996;98:1088\u201394.","journal-title":"J Clin Invest"},{"key":"BF03044692_CR80","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1172\/JCI117002","volume":"93","author":"T Miyata","year":"1994","unstructured":"Miyata T, Inagi R, Ilida Y, et al. Involvement of beta-2-microglobulin modified with advanced glycation end products in the pathogenesis of hemodialysis associated amyloidosis. J Clin Invest 1994;93:521\u20138.","journal-title":"J Clin Invest"},{"key":"BF03044692_CR81","doi-asserted-by":"crossref","unstructured":"Miyazaki S, Niwa T, Morit T, et al. Advanced glycation end products are associated with beta-2-microglobulin amyloidosis. Am J Nephr 1995;15.","DOI":"10.1159\/000168903"},{"key":"BF03044692_CR82","first-page":"1","volume-title":"The Maillard reaction in aging, diabetes and nutrition. NIH conference","author":"V Monnier","year":"1988","unstructured":"Monnier V. The Maillard reaction in aging, diabetes and nutrition. NIH conference. Baynes JW, Monnier V, eds. New York: Liss, 1988:1\u201322."},{"key":"BF03044692_CR83","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1126\/science.6779377","volume":"211","author":"VM Monnier","year":"1981","unstructured":"Monnier VM, Ceramo A. Nonenzymatic browning in vivo: possible process for aging on long lived proteins. Science 1981;211:491\u20133.","journal-title":"Science"},{"key":"BF03044692_CR84","doi-asserted-by":"crossref","first-page":"3","DOI":"10.2337\/diab.41.2.S36","volume":"41","author":"VM Monnier","year":"1992","unstructured":"Monnier VM, Sell DR, Nagaraj RH, et al. Maillard reaction-mediated molecular damage to extracellular matrix and other tissue proteins in diabetes, aging and uremia. Diabetes 1992;41:3\u201341.","journal-title":"Diabetes"},{"key":"BF03044692_CR85","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1016\/S0006-291X(05)80875-7","volume":"173","author":"CJ Mullarkey","year":"1990","unstructured":"Mullarkey CJ, Edelstein D, Brownlee M. Free radical generation by early glycation products a mechanism for accelerated atherogenesis in diabetes. Biochem Biophys Res Commun 1990;173:932\u20139.","journal-title":"Biochem Biophys Res Commun"},{"key":"BF03044692_CR86","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/BF02260940","volume":"8","author":"G M\u00fcnch","year":"1994","unstructured":"M\u00fcnch G, Taneli Y, Schraven E, et al. The cognitionenhancing drug Tenilsetam is an inhibitor of protein crosslinking by advanced glycosylation. J Neural Transm 1994;8:193\u2013208.","journal-title":"J Neural Transm"},{"key":"BF03044692_CR87","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/S0165-0173(96)00016-1","volume":"23","author":"G M\u00fcnch","year":"1997","unstructured":"M\u00fcnch G, Thome J, Foley P, et al. Advanced glycation endproducts in ageing and Alzheimer\u2019s disease. Brain Res Rev 1997;23:134\u201343.","journal-title":"Brain Res Rev"},{"key":"BF03044692_CR88","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.2337\/diacare.18.8.1160","volume":"18","author":"M Nagamatsu","year":"1995","unstructured":"Nagamatsu M, Nickander KK, Schmelzer JD, et al. Lipoic acid improve nerve blood flow, reduces oxidative stress and improves distal nerve conduction in experimental diabetic neuropathy. Diabetes Care 1995;18:1160\u20137.","journal-title":"Diabetes Care"},{"key":"BF03044692_CR89","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/0167-4838(95)00161-M","volume":"1253","author":"R Nagaraj","year":"1995","unstructured":"Nagaraj R, Monnier V. Protein modification by the degradation products of ascorbate: formation of a novel pyrrole from the Maillard reaction of L-threose with proteins. Biochim Biophys Acta 1995;1253:75\u201384.","journal-title":"Biochim Biophys Acta"},{"key":"BF03044692_CR90","doi-asserted-by":"crossref","first-page":"895","DOI":"10.2337\/diab.46.5.895","volume":"46","author":"S Nakamura","year":"1997","unstructured":"Nakamura S, Makita Z, Ishikawa S, et al. Progression of nephropathy in spontaneous diabetic rats is prevented by OPB-9195, a novel inhibitor of advanced glycation. Diabetes 1997;46:895\u20139.","journal-title":"Diabetes"},{"key":"BF03044692_CR91","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/0006-291X(89)92372-3","volume":"162","author":"H Nakayama","year":"1989","unstructured":"Nakayama H, Taneda S, Kuwajima S, et al. Production and characterisation of antibodies to advanced glycation products on proteins. Biochem Biophys Res Commun 1989;162:740\u20135.","journal-title":"Biochem Biophys Res Commun"},{"key":"BF03044692_CR92","first-page":"14998","volume":"267","author":"M Neeper","year":"1992","unstructured":"Neeper M, Schmidt AM, Brett J, et al. Cloning and expression of a cell surface receptor for advanced glycosylation end products of proteins. J Biol Chem 1992;267:14998\u201315004.","journal-title":"J Biol Chem"},{"key":"BF03044692_CR93","first-page":"486","volume":"60","author":"K Nicholls","year":"1989","unstructured":"Nicholls K, Mandel TE. Advanced glycosylation end-products in experimental murine diabetic nephropathy: efect of islet isografting and of aminoguanidine. Lab Invest 1989;60:486\u201391.","journal-title":"Lab Invest"},{"key":"BF03044692_CR94","first-page":"85","volume":"304","author":"FG Njorge","year":"1989","unstructured":"Njorge FG, Monnier VM. The chemistry of the maillard reaction under physiological conditions: a review. Prog Clin Biol Res 1989;304:85\u2013107.","journal-title":"Prog Clin Biol Res"},{"issue":"Suppl 2","key":"BF03044692_CR95","first-page":"20","volume":"6","author":"J Nourooz-Zadeh","year":"1997","unstructured":"Nourooz-Zadeh J, Halliwell B, Tritschler H, et al. Decreased lipid standardised plasma a-tocopherol in non-insulin dependent diabetes mellitus. Diab Stoffw 1997;6:Suppl 2:20\u20133.","journal-title":"Diab Stoffw"},{"key":"BF03044692_CR96","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.2337\/diab.44.9.1054","volume":"44","author":"J Nourooz-Zadeh","year":"1995","unstructured":"Nourooz-Zadeh J, Tajaddini-Samadi J, McCarthy S, et al. Elevated levels of authentic plasma hydroperoxides in NIDDM. Diabetes 1995;44:1054\u20138.","journal-title":"Diabetes"},{"key":"BF03044692_CR97","doi-asserted-by":"crossref","first-page":"796","DOI":"10.2337\/diab.39.7.796","volume":"39","author":"PR Odetti","year":"1990","unstructured":"Odetti PR, Borgoglio A, De Pascale A, et al. Prevention of diabetes-increased aging effect on rat collagen-linked flurescence by aminoguanidine and rutin. Diabetes 1990;39:796\u2013801.","journal-title":"Diabetes"},{"key":"BF03044692_CR98","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1016\/0006-2952(93)90461-5","volume":"43","author":"P Ou","year":"1993","unstructured":"Ou P, Wolff SP. Aminoguanidine: a drug proposed for the prophylaxis in diabetes inhibits catalase and generates hydrogen peroxide in vitro. Biochem Pharmacol 1993;43:1139\u201344.","journal-title":"Biochem Pharmacol"},{"key":"BF03044692_CR99","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/BF00400847","volume":"35","author":"H Oxlund","year":"1992","unstructured":"Oxlund H, Andreassen TT. Aminoguanidine treatment reduces the increase in collagen stability of rats with experimental diabetes mellitus. Diabetolgia 1992;35:75\u20138.","journal-title":"Diabetolgia"},{"key":"BF03044692_CR100","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1161\/01.ATV.15.5.571","volume":"15","author":"W Palinski","year":"1995","unstructured":"Palinski W, Koschinsky T, Butler SW, et al. Immunological evidence for the presence of advanced glycation end products in atherosclerotic lesions of euglycemic rabbits. Arterioscl Thromb Vasc Biol 1995;15:571\u201382.","journal-title":"Arterioscl Thromb Vasc Biol"},{"key":"BF03044692_CR101","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1021\/bi00002a032","volume":"34","author":"A Papoulis","year":"1995","unstructured":"Papoulis A, Youssef A, Bucala R. Identification of N2-(1-carboxyethyl) guanine (CEG) as a guanine advanced glycosylation end product. Biochemistry 1995;34:648\u201355.","journal-title":"Biochemistry"},{"key":"BF03044692_CR102","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1161\/01.ATV.15.3.367","volume":"15","author":"A Philis-Tsimikas","year":"1995","unstructured":"Philis-Tsimikas A, Parthasarathy S, Picard S, et al. Aminoguanidine has both pro-oxidant and antioxidant activity toward LDL. Arterioscler Thromb Vasc Biol 1995;15:367\u201376.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"BF03044692_CR103","doi-asserted-by":"crossref","first-page":"6876","DOI":"10.1073\/pnas.89.15.6876","volume":"89","author":"S Picard","year":"1991","unstructured":"Picard S, Parthasarathy S, Fruebis J, et al. Aminoguanidine inhibits oxidative modifications of low density lipoprotein and the subsequent increase in uptake by macrophage scavenger receptors. Proc Natl Acad Sci USA 1991;89:6876\u201380.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF03044692_CR104","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0891-5849(91)90073-C","volume":"10","author":"WA Pryor","year":"1991","unstructured":"Pryor WA, Godber SS. Noninvasive measures of oxidative stress status in humans. Free Rad Biol Med 1991;10:177\u201384.","journal-title":"Free Rad Biol Med"},{"key":"BF03044692_CR105","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1016\/0026-0495(94)90003-5","volume":"43","author":"RA Rabini","year":"1994","unstructured":"Rabini RA, Fumelli P, Galassi R, et al. Increased suspectibility of lipid peroxidation of low-density lipoproteins and erythrocyte membranes from diabetic patients. Metabolism 1994;43:1470\u20134.","journal-title":"Metabolism"},{"key":"BF03044692_CR106","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.2337\/diab.39.12.1510","volume":"39","author":"S Radoff","year":"1990","unstructured":"Radoff S, Cerami A, Vlassara H. Isolation of a surface binding protein specific for advanced glycosylation end products from the murine macrophage derived cell line RAW 264.7. Diabetes 1990;39:1510\u20138.","journal-title":"Diabetes"},{"key":"BF03044692_CR107","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.2337\/diab.40.12.1731","volume":"40","author":"S Radoff","year":"1991","unstructured":"Radoff S, Makita Z, Vlassara H. Radioreceptor assay for advanced glycosylation end products. Diabetes 1991;40: 1731\u20138.","journal-title":"Diabetes"},{"key":"BF03044692_CR108","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/0003-9861(88)90654-6","volume":"263","author":"S Radoff","year":"1988","unstructured":"Radoff S, Vlassara H, Cerami A. Characterisation and isolation of a macrophage receptor for advanced glycosylation end products. Arch Biochem Biophys 1988;263:418\u201323.","journal-title":"Arch Biochem Biophys"},{"key":"BF03044692_CR109","first-page":"984","volume":"39","author":"H Reinauer","year":"1993","unstructured":"Reinauer H. Biochemistry of protein glycation in diabetes mellitus. Klin Lab 1993;39:984\u20137.","journal-title":"Klin Lab"},{"key":"BF03044692_CR110","first-page":"688","volume":"146","author":"U Ritthaler","year":"1995","unstructured":"Ritthaler U, Deng Y, Zhang Y, et al. Expression of receptors for advanced glycation end products in peripheral occlusive vascular disease. Am J Pathol 1995;146:688\u201394.","journal-title":"Am J Pathol"},{"key":"BF03044692_CR111","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/ndt\/9.supp.120","volume":"9","author":"E Ritz","year":"1994","unstructured":"Ritz E, Deppisch R, Nawroth P. Toxicity of uraemia \u2014 does it come of AGE? Nephrol Dial Transplant 1994;9:1\u20132.","journal-title":"Nephrol Dial Transplant"},{"key":"BF03044692_CR112","first-page":"81A","volume":"40","author":"B Robinson","year":"1992","unstructured":"Robinson B, van der Jagd DL, Taylor KK, et al. A new integrative theory of diabetic complications. Clin Res 1992;40:81A","journal-title":"Clin Res"},{"key":"BF03044692_CR113","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/0021-9150(95)05526-3","volume":"116","author":"N Sakata","year":"1995","unstructured":"Sakata N, Meng J, Jinn S, et al. Nonenzymatic glycatin and extractability of collagen in human atherosclerotic plaques. Atherosclerosis 1995;116:63\u201375.","journal-title":"Atherosclerosis"},{"key":"BF03044692_CR114","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1161\/01.ATV.14.10.1521","volume":"14","author":"AM Schmidt","year":"1994","unstructured":"Schmidt AM, Hori O, Breet J, Yan SD, et al. Cellular receptors for advanced glycation end products. Implications for induction of oxidant stress and cellular dysfumction in the pathogenesis of vascular lesions. Arterioscler Thromb 1994;14:1521\u20138.","journal-title":"Arterioscler Thromb"},{"key":"BF03044692_CR115","first-page":"9882","volume":"269","author":"AM Schmidt","year":"1994","unstructured":"Schmidt AM, Mora R, Cao R, et al. The endothelial cell binding site for advanced glycation end products consists of a complex: an integral membrane protein and a lactoferrin-like polypeptide. J Biol Chem 1994;269:9882\u20138.","journal-title":"J Biol Chem"},{"key":"BF03044692_CR116","first-page":"14987","volume":"267","author":"AM Schmidt","year":"1992","unstructured":"Schmidt AM, Vianna M, Gerlach M, et al. Isolation and characterisation of binding proteins for advanced glycation end products from lung tissue which are present on the endothelial surface. J Biol Chem 267 (1992), 14987\u201397.","journal-title":"J Biol Chem"},{"key":"BF03044692_CR117","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1038\/nm1095-1002","volume":"1","author":"AM Schmidt","year":"1995","unstructured":"Schmidt AM, Yan SD, Stern DM. The dark side of glucose. Nature Med 1995;1:1002\u20134.","journal-title":"Nature Med"},{"key":"BF03044692_CR118","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1172\/JCI114449","volume":"85","author":"DR Sell","year":"1990","unstructured":"Sell DR, Monnier V. End-stage renal disease and diabetes catalyze the formation of a pentose-derived crosslink from aging human collagen. J Clin Invest 1990;85:380\u20134.","journal-title":"J Clin Invest"},{"issue":"Suppl 2","key":"BF03044692_CR119","first-page":"16","volume":"6","author":"I Simone-Schna\u00df","year":"1997","unstructured":"Simone-Schna\u00df I, Rosak C, Tritschler HJ, et al. Alpha-Tocopherolaufnahme und -zufuhr bei Typ-II-Diabetikern. Diab Stoffw 1997;6:Suppl 2:16\u20139.","journal-title":"Diab Stoffw"},{"key":"BF03044692_CR120","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/BF00418271","volume":"34","author":"AJ Sinclair","year":"1991","unstructured":"Sinclair AJ, Girling AJ, Gray L, et al. Disturbed handling of ascorbic acid in diabetic patients with and without microangiopathy during high dose ascorbate supplementation. Diabetologia 1991;34:171\u20135.","journal-title":"Diabetologia"},{"key":"BF03044692_CR121","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1111\/j.1464-5491.1994.tb00375.x","volume":"11","author":"AJ Sinclair","year":"1994","unstructured":"Sinclair AJ, Taylor PB, Lunec J, et al. Low plasma ascorbate in patients with type 2 diabetes mellitus consuming adaequate dietary vitamin C. Diabet Med 1994;11:893\u20138.","journal-title":"Diabet Med"},{"key":"BF03044692_CR122","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.2337\/diab.40.10.1328","volume":"40","author":"T Soulis-Liparota","year":"1991","unstructured":"Soulis-Liparota T, Cooper M, Papazoglou D, et al. Retardation by aminoguanidine of development of albuminuria, mesangial expansion and tissue fluorescence in streptozocin-induced diabetic rats. Diabetes 1991;40:1328\u201334.","journal-title":"Diabetes"},{"key":"BF03044692_CR123","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/0049-3848(95)90177-H","volume":"76","author":"S Srivastava","year":"1994","unstructured":"Srivastava S, Joshi CS, Sethi PP, et al. Altered platelet function in non-insulin-dependent diabetes mellitus (NIDDM). Thromb Res 1994:76:451\u201361.","journal-title":"Thromb Res"},{"key":"BF03044692_CR124","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/S0140-6736(96)90866-1","volume":"347","author":"NG Stephens","year":"1996","unstructured":"Stephens NG, Parsons A, Schofield PM, et al. Randomised controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study (CHAOS). Lancet 1996;347:781\u20136.","journal-title":"Lancet"},{"key":"BF03044692_CR125","doi-asserted-by":"crossref","first-page":"2918","DOI":"10.1073\/pnas.75.6.2918","volume":"75","author":"VJ Stevens","year":"1978","unstructured":"Stevens VJ, Rouzer CA, Monnier VM, et al. Diabetic cataract formation: potential role of glycosylation of lens crystallins. Proc Natl Acad Sci USA 1978;75:2918\u201322.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF03044692_CR126","doi-asserted-by":"crossref","first-page":"211","DOI":"10.3109\/10715769209068167","volume":"17","author":"YJ Suzuki","year":"1992","unstructured":"Suzuki YJ, Tsuchiya M, Packer L. Lipoate prevents glucose-induced protein modifications. Free Radic Res Commun 1992;17:211\u20137.","journal-title":"Free Radic Res Commun"},{"key":"BF03044692_CR127","first-page":"14819","volume":"263","author":"K Takara","year":"1988","unstructured":"Takara K, Horiuchi S, Araki M, et al. Endocytic uptake of nonenzymatically glycosylated proteins is mediated by a scavenger receptor for aldehyde-modified proteins. J Biol Chem 1988;263:14819\u201325.","journal-title":"J Biol Chem"},{"key":"BF03044692_CR128","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/0005-2736(89)90267-8","volume":"986","author":"K Takata","year":"1989","unstructured":"Takata K, Horiuchi S, Araki N, et al. Scavenger receptor of human leukemia cell line (THP-1) and murine macrophages for nonenzymatically glycosylated proteins. Biochim Biophys Acta 1989;986:18\u201326.","journal-title":"Biochim Biophys Acta"},{"key":"BF03044692_CR129","doi-asserted-by":"crossref","first-page":"221","DOI":"10.2337\/diab.42.2.221","volume":"43","author":"R Tilton","year":"1993","unstructured":"Tilton R, Chang K, Hasan K, et al. Prevention of vascular dysfunction by guanidines. Diabetes 1993;43: 221\u201332.","journal-title":"Diabetes"},{"issue":"Suppl 2","key":"BF03044692_CR130","first-page":"11","volume":"6","author":"MG Traber","year":"1997","unstructured":"Traber MG. Relationship of plasma and dietary vitamin E. Diab Stoffw 1997;6:Suppl 2:11\u20135.","journal-title":"Diab Stoffw"},{"key":"BF03044692_CR131","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1038\/382275a0","volume":"382","author":"S Vasan","year":"1996","unstructured":"Vasan S, Zhang X, Zhang X, et al. An agent cleaving glucose-derived protein crosslinks in vitro and in vivo. Nature 1996;382:275\u20138.","journal-title":"Nature"},{"issue":"Suppl 51","key":"BF03044692_CR132","first-page":"43","volume":"48","author":"H Vlassara","year":"1995","unstructured":"Vlassara H. Advanced glycation in diabetic renal and vascular disease. Kidney Int 1995;48:Suppl 51:43\u20134.","journal-title":"Kidney Int"},{"key":"BF03044692_CR133","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1038\/ki.1996.270","volume":"49","author":"H Vlassara","year":"1996","unstructured":"Vlassara H. Protein glycation in the kidney: role in diabetes and aging. Kidney Int 1996;49:1795\u20131804.","journal-title":"Kidney Int"},{"key":"BF03044692_CR134","doi-asserted-by":"crossref","first-page":"419","DOI":"10.3109\/07853899608999102","volume":"28","author":"H Vlassara","year":"1996","unstructured":"Vlassara H. Advanced glycation end-products and atherosclerosis. Ann Med 1996;28:419\u201326.","journal-title":"Ann Med"},{"issue":"Suppl 1","key":"BF03044692_CR135","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/BF03041807","volume":"92","author":"H Vlassara","year":"1997","unstructured":"Vlassara H. Pathogenesis of diabetic nephropathy, advanced glycation and new therapy. Med Klin 1997;92:Suppl 1:29\u201334.","journal-title":"Med Klin"},{"key":"BF03044692_CR136","doi-asserted-by":"crossref","first-page":"5588","DOI":"10.1073\/pnas.82.17.5588","volume":"82","author":"H Vlassara","year":"1985","unstructured":"Vlassara H, Brownlee M, Cerami A. High affinity receptor mediated uptake and degradation of glucose modified proteins: a potential mechanism for the removal of senscent macromolecules. Proc Natl Acad Sci USA 1985;82:5588\u201392.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF03044692_CR137","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1084\/jem.164.4.1301","volume":"164","author":"H Vlassara","year":"1986","unstructured":"Vlassara H, Brownlee M, Cerami A. The novel macrophage receptor for glucose-modified proteins is distinct from previously described scavenger-receptors. J Exp Med 1986;164:1301\u20139.","journal-title":"J Exp Med"},{"key":"BF03044692_CR138","doi-asserted-by":"crossref","first-page":"456","DOI":"10.2337\/diab.37.4.456","volume":"37","author":"H Vlassara","year":"1988","unstructured":"Vlassara H, Brownlee M, Cerami A. Specific macrophage receptor activity for advanced glycosylation end products inversely correlates with insulin levels in vivo. Diabetes 1988;37:456\u201361.","journal-title":"Diabetes"},{"key":"BF03044692_CR139","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1126\/science.3259727","volume":"240","author":"H Vlassara","year":"1988","unstructured":"Vlassara H, Brownlee M, Manogue KR, et al. Cachectin\/TNF and IL1 induced by glucose-modified proteins: role in normal tissue remodelling. Science 1988;240:1546\u20138.","journal-title":"Science"},{"key":"BF03044692_CR140","first-page":"138","volume":"70","author":"H Vlassara","year":"1994","unstructured":"Vlassara H, Bucala R, Striker L. Pathogenic effects of advanced glycosylation: biochemical, biological and clinical implications for diabetes and aging. Lab Invest 1994;70:138\u201351.","journal-title":"Lab Invest"},{"key":"BF03044692_CR141","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1007\/BF03401582","volume":"1","author":"H Vlassara","year":"1995","unstructured":"Vlassara H, Fuh H, Donnelly T, et al. Advanced glycation endproducts promote adhesion molecule (VCAM-1, ICAM-1) expression and atheroma formation in normal rabbits. Mol Med 1995;1:447\u201356.","journal-title":"Mol Med"},{"key":"BF03044692_CR142","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1007\/BF03401604","volume":"1","author":"H Vlassara","year":"1996","unstructured":"Vlassara H, Li Y-M, Imani F, et al. Identification of galectin-3 as a high affinity binding protein for advanced glycation end products (AGEs): a new member of the AGE-receptor complex. Mol Med 1996;1:634\u201346.","journal-title":"Mol Med"},{"key":"BF03044692_CR143","doi-asserted-by":"crossref","first-page":"11704","DOI":"10.1073\/pnas.91.24.11704","volume":"91","author":"H Vlassara","year":"1994","unstructured":"Vlassara H, Striker LJ, Teichberg S, et al. Advanced glycation end products induce glomerular sclerosis and albuminuria in normal rats. Proc Natl Acad Sci USA 1994;91:11704\u20138.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF03044692_CR144","doi-asserted-by":"crossref","first-page":"7742","DOI":"10.1073\/pnas.91.16.7742","volume":"91","author":"JL Wautier","year":"1994","unstructured":"Wautier JL, Wautier MP, Schmidt AM, et al. Advanced glycation end products (AGEs) on the surface of diabetic erythrocytes bind to the vessel wall via a specific receptor inducing oxidant stress in the vasculature: a link between surface-associated AGEs and diabetic complications. Proc Natl Acad Sci USA 1994;91:7742\u20136.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF03044692_CR145","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1172\/JCI118397","volume":"97","author":"JL Wautier","year":"1996","unstructured":"Wautier JL, Zoukourian C, Chappey O, et al. Receptormediated endothelial cell dysfunction in diabetic vasculopathy. Soluble receptor for advanced glycation end products blocks hyperpermeability in diabetic rats. J Clin Invest 1996;97:238\u201343.","journal-title":"J Clin Invest"},{"key":"BF03044692_CR146","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.2337\/diab.43.9.1152","volume":"443","author":"KJ Wells-Knecht","year":"1994","unstructured":"Wells-Knecht KJ, Lyons TJ, Lyons TJ, et al. 3-Desoxyfructose concentrations are increased in human plasma and urine in diabetes. Diabetes 1994;443:1152\u20136.","journal-title":"Diabetes"},{"key":"BF03044692_CR147","doi-asserted-by":"crossref","first-page":"3702","DOI":"10.1021\/bi00011a027","volume":"34","author":"KJ Wells-Knecht","year":"1995","unstructured":"Wells-Knecht KJ, Zyzak DV, Litchfield JE, et al. Mechanism of autoxidative glycosylation: identification of glyoxal and arabinose as intermediates in the autoxidative modification of proteins by glucose. Biochemistry 1995;34:3702\u20139.","journal-title":"Biochemistry"},{"key":"BF03044692_CR148","doi-asserted-by":"crossref","first-page":"15134","DOI":"10.1021\/bi00046a020","volume":"34","author":"M Wells-Knecht","year":"1995","unstructured":"Wells-Knecht M, Thorpe SR, Baynes JW. Pathways of formation of glycoxidation products during glycation of collagen. Biochemistry 1995;34:15134\u2013141.","journal-title":"Biochemistry"},{"key":"BF03044692_CR149","first-page":"454","volume":"91","author":"J Wisotzky","year":"1996","unstructured":"Wisotzky J, Sommer M, Schubert K, et al. Die Akkumulation von AGEs im Alterungsproze\u00df, bei Diabetes mellitus und bei der chronischen Niereninsuffizienz. Med Klin 1996;91:454\u20137.","journal-title":"Med Klin"},{"key":"BF03044692_CR150","doi-asserted-by":"crossref","first-page":"47","DOI":"10.2337\/diab.41.1.47","volume":"41","author":"S Yagihashi","year":"1992","unstructured":"Yagihashi S, Kamijo M, Baba M, et al. Effects of aminoguanidine on functional and structural abnormalitis in peripheral nerve of STZ-induced diabetic rats. Diabetes 1992;41:47\u201352.","journal-title":"Diabetes"},{"key":"BF03044692_CR151","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1038\/382685a0","volume":"382","author":"SD Yan","year":"1996","unstructured":"Yan SD, Chen X, Fu J, et al. RAGE and amyloid-b-peptide neurotoxicity in Alzheimer\u2019s disease. Nature 1996;382:685\u201391.","journal-title":"Nature"},{"key":"BF03044692_CR152","first-page":"9889","volume":"269","author":"SD Yan","year":"1994","unstructured":"Yan SD, Schmidt AM, Anderson GM, et al. Enhanced cellular oxidant stress by the interaction of advanced glycation end products with their receptors\/binding proteins. J Biol Chem 1994;269:9889\u201397.","journal-title":"J Biol Chem"},{"key":"BF03044692_CR153","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1038\/nm0795-693","volume":"1","author":"S-D Yan","year":"1995","unstructured":"Yan S-D, Yan SF, Chen X, et al. Non-enzymatically glycated tau in Alzheimer\u2019s disease induceds neuronal oxidant stress resulting in cytokine gene expression and release of amyloid b-peptide. Nat Med 1995;1:693\u20139.","journal-title":"Nat Med"},{"key":"BF03044692_CR154","doi-asserted-by":"crossref","first-page":"9436","DOI":"10.1073\/pnas.91.20.9436","volume":"91","author":"CW Yang","year":"1994","unstructured":"Yang CW, Vlassara H, Peten EP, et al. Advanced glycation endproducts upregulate gene expression found in diabetic glomerular disease. Proc Natl Acad Sci USA 1994;91:9436\u201340.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF03044692_CR155","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1084\/jem.174.3.515","volume":"174","author":"Z Yang","year":"1991","unstructured":"Yang Z, Makita Z, Horii Y, et al. Two novel rat liver membrane proteins that bind advanced glycosylation endoproducts: relationship to macrophage receptor for glucose-modified proteins. J Exp Med 1991;174: 515\u201324.","journal-title":"J Exp Med"},{"key":"BF03044692_CR156","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1007\/BF00400603","volume":"38","author":"D Ziegler","year":"1995","unstructured":"Ziegler D, Hanefeld M, Ruhnau KJ, et al. Treatment of symptomatic diabetic peripheral neuropathy with the anti-oxidant a-lipoic acid. Diabetologia 1995;38: 1425\u201333.","journal-title":"Diabetologia"}],"container-title":["Medizinische Klinik"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03044692.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF03044692\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03044692","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,21]],"date-time":"2019-05-21T23:49:29Z","timestamp":1558482569000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF03044692"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1999,1]]},"references-count":156,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1999,1]]}},"alternative-id":["BF03044692"],"URL":"https:\/\/doi.org\/10.1007\/bf03044692","relation":{},"ISSN":["0723-5003","1615-6722"],"issn-type":[{"value":"0723-5003","type":"print"},{"value":"1615-6722","type":"electronic"}],"subject":[],"published":{"date-parts":[[1999,1]]}}}